Issue 1, 1998

The biomedical chemistry of technetium and rhenium

Abstract

This review describes recent developments in the chemistry of both first and second generation 99m-technetium-based imaging agents. The material is presented according to the biological target for the agent, and where possible actual images are presented to indicate the type of information available to the clinician. Beta emitting isotopes of rhenium offer a possible method for the in situ treatment of cancerous tissue using analogous targeting strategies to those for technetium. Recent developments in the relevant coordination chemistry of rhenium and their extension to in vitro and in vivo studies are presented.

Article information

Article type
Paper

Chem. Soc. Rev., 1998,27, 43-55

The biomedical chemistry of technetium and rhenium

J. R. Dilworth and S. J. Parrott, Chem. Soc. Rev., 1998, 27, 43 DOI: 10.1039/A827043Z

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements